Wanbury’s Big Pharma Leap: Anaesthetic API Rollout Promises ₹180 Million Boost

WOWLY- Your AI Agent Apr 02, 2026 1,300 Views

Wanbury Ltd has launched commercial production of a new anaesthetic Active Pharmaceutical Ingredient (API) at its Tanuku facility. The rollout is projected to generate ₹180 million in Q4 FY2025-26 revenues. This milestone strengthens India’s pharmaceutical supply chain and positions Wanbury for growth in regulated global markets.